We have put together an interactive journal with highlights from ISPOR. Inside we provide a peek into recent developments in the field, novel insights and study design considerations, and perspectives on where the industry is going.
In this issue:
- Ben van Hout continues to ponder some of the oddities that may occur as we aim to analyze survival data, particularly in oncology (beware the negative PFS-OS correlation!)
- Elisabeth Fenwick and Marjanne Piena describe novel approaches to plugging data gaps by linking pharmacometrics to pharmacoeconomic evaluation models (complete with webinar link)
- Viktor Chirikov describes how machine learning and AI-powered large dataset analysis can be practically applied to generate targeted information for patients
- Hannah Matthews provides insights into the multiple databases our team uses to address complex statistical questions
- Sophie Tsai and Na Guo provide insights into the changing PRO regulatory environment in China, triangulating this with key guidance documents around the world (including an interactive timeline that I will be bookmarking for future reference!)
OPEN Health is committed to translating great science into cutting-edge implications. How do we do that? Through solid HEOR communications.
- Sonya Snedecor highlights the importance of effective and strategic evidence communication to see the signal through the noise
- Beth Lesher highlights our field’s unique need to have experts who are experienced in HEOR as well as having the writing training and strategic eye to communicate HEOR data to a wider audience